SCHEMBL25874132

SCHEMBL25874132

Cc1nonc1C(=O)NN

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 4/20 0.46
ALDH1A1 P00352 3/20 0.45
RXFP1 Q9HBX9 1/20 0.45
GAA P10253 4/20 0.42
ALPL P05186 1/20 0.42
ALPI P09923 1/20 0.42
ALPG P10696 1/20 0.42
HPGD P15428 1/20 0.42
RAB9A P51151 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
NOD2 Q9HC29 2/20 0.42
MEN1 O00255 1/20 0.42
LMNA P02545 1/20 0.42
MAPT P10636 1/20 0.42
HTT P42858 1/20 0.42
KMT2A Q03164 1/20 0.42
NOD1 Q9Y239 1/20 0.42
CYP1A2 P05177 2/20 0.40
CYP3A4 P08684 2/20 0.40
KDM4E B2RXH2 3/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL30404835 0.98 PKM (0.45) PKMALDH1A1RXFP1GAAALPL
SCHEMBL29184492 0.83 PKM (0.49) PKMALDH1A1RXFP1GAAALPL
SCHEMBL354093 0.81 PKM (0.47) PKMALDH1A1RXFP1GAAALPL
SCHEMBL25481082 0.80 PKM (0.44) PKMALDH1A1RXFP1GAAALPL
SCHEMBL18249667 0.77 ALDH1A1 (0.51) ALDH1A1GAASMN1; SMN2MAPTKMT2A
SCHEMBL24130245 0.76 PKM (0.47) PKMALDH1A1RXFP1GAAALPL
SCHEMBL23135525 0.76 PKM (0.44) PKMALDH1A1RXFP1GAAALPL
SCHEMBL353456 0.76
SCHEMBL23366884 0.75 PKM (0.36) PKMALDH1A1RXFP1GAAALPL
SCHEMBL25447714 0.75 PKM (0.43) PKMALDH1A1RXFP1GAAALPL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230227435-A1 SMALL MOLECULE MODULATORS OF IL-17 LEO PHARMA A/S (DK) 2023-07-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230227435-A1 SMALL MOLECULE MODULATORS OF IL-17 IL17A, IL2, IL23R PKM 3171/4885ALDH1A1 448/4885RXFP1 2282/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.